Seroatlas · Human Serome Atlas

ATP13A5

Probable cation-transporting ATPase 13A5

Also known as: AT135_HUMAN, FLJ16025

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q4VNC0
Gene
ATP13A5
Ensembl
ENSG00000187527
Chromosome
3
Canonical length
1218 aa
Protein class
Predicted membrane proteins
Subcellular location
Nucleoplasm,Plasma membrane

OverviewNCBI Gene

This gene encodes a member of the P5 subfamily of P-type transport ATPases. P-type ATPases form a large superfamily of cation and lipid pumps that transport inorganic cations and other substrates across cell membranes. P5 ATPases are localized to membranes of the endoplasmic reticulum (ER) and serve many important functions including transport of cargo proteins to the Golgi, glycosylation and cell wall biosynthesis, control of protein insertion orientation, 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) degradation, and sensitivity to unfolded protein response (UPR) activators. The encoded protein is organized into three cytoplasmic domains (A, P, and N) and two membrane-embedded domains (T and S). The N-domain binds ATP and serves as a built-in protein kinase, which phosphorylates the P-domain. The A-domain is an intrinsic protein phosphatase, which dephosphorylates the P-domain once during each catalytic cycle. [provided by RefSeq, Jul 2017]

Canonical amino-acid sequenceUniProt

1218 residues, UniProt reviewed canonical sequence.

>Q4VNC0|ATP13A5
     1  MEENSKKDHR ALLNQGEEDE LEVFGYRDHN VRKAFCLVAS VLTCGGLLLV FYWRPQWRVW
    61  ANCIPCPLQE ADTVLLRTTD EFQRYMRKKV FCLYLSTLKF PVSKKWEESL VADRHSVINQ
   121  ALIKPELKLR CMEVQKIRYV WNDLEKRFQK VGLLEDSNSC SDIHQTFGLG LTSEEQEVRR
   181  LVCGPNAIEV EIQPIWKLLV KQVLNPFYVF QAFTLTLWLS QGYIEYSVAI IILTVISIVL
   241  SVYDLRQQSV KLHNLVEDHN KVQVTIIVKD KGLEELESRL LVPGDILILP GKFSLPCDAV
   301  LIDGSCVVNE GMLTGESIPV TKTPLPQMEN TMPWKCHSLE DYRKHVLFCG TEVIQVKPSG
   361  QGPVRAVVLQ TGYNTAKGDL VRSILYPRPL NFKLYSDAFK FIVFLACLGV MGFFYALGVY
   421  MYHGVPPKDT VTMALILLTV TVPPVLPAAL TIGNVYAQKR LKKKKIFCIS PQRINMCGQI
   481  NLVCFDKTGT LTEDGLDLWG TVPTADNCFQ EAHSFASGQA VPWSPLCAAM ASCHSLILLN
   541  GTIQGDPLDL KMFEGTAWKM EDCIVDSCKF GTSVSNIIKP GPKASKSPVE AIITLCQFPF
   601  SSSLQRMSVI AQLAGENHFH VYMKGAPEMV ARFCRSETVP KNFPQELRSY TVQGFRVIAL
   661  AHKTLKMGNL SEVEHLAREK VESELTFLGL LIMENRLKKE TKLVLKELSE ARIRTVMITG
   721  DNLQTAITVA KNSEMIPPGS QVIIVEADEP EEFVPASVTW QLVENQETGP GKKEIYMHTG
   781  NSSTPRGEGG SCYHFAMSGK SYQVIFQHFN SLLPKILVNG TVFARMSPGQ KSSLIEEFQK
   841  LNYYVGMCGD GANDCGALKA AHAGISLSEQ EASVASPFTS KTTNIQCVPH LIREGRAALV
   901  SSFGVFKYLT MYGIIQFISA LLLYWQLQLF GNYQYLMQDV AITLMVCLTM SSTHAYPKLA
   961  PYRPAGQLLS PPLLLSIFLN SCFSCIVQIS AFLYVKQQPW YCEVYQYSEC FLANQSNFST
  1021  NVSLERNWTG NATLIPGSIL SFETTTLWPI TTINYITVAF IFSKGKPFRK PIYTNYIFSF
  1081  LLLAALGLTI FILFSDFQVI YRGMELIPTI TSWRVLILVV ALTQFCVAFF VEDSILQNHE
  1141  LWLLIKREFG FYSKSQYRTW QKKLAEDSTW PPINRTDYSG DGKNGFYING GYESHEQIPK
  1201  RKLKLGGQPT EQHFWARL

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ATP13A5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
10
Mean surface accessibility (rSASA)
0.27
Highest tissue expression
33 nTPM

Expression across tissuesHPA

Tissue

  • choroid plexus: 33 nTPM
  • breast: 16 nTPM
  • salivary gland: 11 nTPM
  • skin: 2.7 nTPM
  • stomach: 1.4 nTPM
  • skeletal muscle: 1.2 nTPM

Single-cell type

  • choroid plexus epithelial cells: 359 nCPM
  • astrocytes: 64 nCPM
  • cone photoreceptor cells: 37 nCPM
  • foveolar cells: 36 nCPM
  • oligodendrocyte progenitor cells: 33 nCPM
  • bergmann glia: 31 nCPM

Immune cell

  • neutrophil: 1 nTPM
  • basophil: 0.1 nTPM
  • eosinophil: 0.1 nTPM
  • naive B-cell: 0.1 nTPM
  • plasmacytoid DC: 0.1 nTPM
  • classical monocyte: 0 nTPM

Brain region

  • choroid plexus: 82 nTPM
  • hippocampal formation: 6.8 nTPM
  • thalamus: 5.7 nTPM
  • midbrain: 5.1 nTPM
  • amygdala: 4.9 nTPM
  • basal ganglia: 4.6 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.29
gnomAD pLI
0
gnomAD missense Z
0.61
DepMap mean gene effect
0.09
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ATP13A5 as an antibody target. Whether an autoantibody or antibody against ATP13A5 could matter depends on whether native ATP13A5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ATP13A5 is annotated at the cell surface, where native ATP13A5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label ATP13A5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ATP13A5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...